Targeted ablation for ventricular tachycardia
Part of Heart & circulation clinical trials.
This study tests a targeted approach to treat ventricular tachycardia (a fast, abnormal heart rhythm) by finding and destroying the specific scar tissue in the heart that causes it. The goal is to improve the success of the standard ablation procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have structural heart disease (a heart condition that changes the heart's structure).
- You are scheduled to have a procedure called ventricular tachycardia ablation.
- You are able to give your consent to participate.
- You are not in cardiogenic shock or severe heart failure that cannot be supported with a mechanical device during the procedure.
- Your doctor can find the scar tissue that is causing the abnormal rhythm during the initial mapping.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new approach to treating a fast, dangerous heart rhythm (ventricular tachycardia) that comes from scar tissue in people with ischemic cardiomyopathy. The goal is to use a special mapping technique to guide the ablation (a procedure that destroys the tiny area causing the problem) to stop the arrhythmia.
This trial tests a new way of mapping the heart's electrical activity during a procedure called catheter ablation, which aims to treat a fast heart rhythm problem called ventricular tachycardia (VT). The hope is that this personalised approach will make the procedure more effective in stopping these abnormal rhythms.
This study tests a new way to find the exact spot in the heart that causes rapid heartbeats, so doctors can treat it more precisely with a procedure called catheter ablation.
This trial tests a new catheter system (Sphere-9 and Affera) to treat a fast, dangerous heartbeat called ventricular tachycardia (VT) in people with heart scarring. It aims to see if this system is safe and effective at stopping VT, especially if past treatments haven't worked.
This study compares an “outer heart” catheter approach (epicardial) versus an “inner heart” approach (endocardial-only) to treat a dangerous heart rhythm called ventricular tachycardia. It aims to see which approach works better and is safest for people with ischemic heart disease who are having their first ablation.
This trial tests a new way to treat rapid heartbeats from the lower chambers (ventricles) using a special catheter that delivers short electrical pulses to stop the abnormal signals. It may help people with extra beats (PVCs) or a fast heart rhythm (ventricular tachycardia) that needs treatment.
Hear when a new Ischemic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.